Figure 2.

Changes in CD20+ B cells. Median percentage change from baseline in CD20+ B cells in (a) single-dose cohorts and (b) double-dose cohorts. Arrows indicate time of belimumab administration.

Furie et al. Arthritis Research & Therapy 2008 10:R109   doi:10.1186/ar2506
Download authors' original image